DEVELOPMENT AND EVALUATION OF IN SITU GELLING GASTRORETENTIVE FORMULATIONS OF MELOXICAM

  • Anyanwu NC J Department of Biological Science, Faculty of Science and Technology, Bingham University, Karu, Nigeria
  • Adogo L Y Department of Biological Science, Faculty of Science and Technology, Bingham University, Karu, Nigeria
  • Ajide B Department of Biological Science, Faculty of Science and Technology, Bingham University, Karu, Nigeria

Abstract

The aim of this study was to develop a novel gastro retentive oral floating in situ gelling system for controlled release of Meloxicam. Meloxicam is a NSAID that inhibits cyclooxygenase (COX) synthesis and has analgesic and antipyretic effects. Four polymer based floating in situ gelling systems of Meloxicam were prepared by dissolving varying concentrations of different ingredients including sodium alginate, HPMC K100M, calcium carbonate, sodium citrate. The prepared gels were characterized for solution viscosity, pH, gelling capacity, floating lag time, floating duration and in-vitro release study. All the formulations showed instant gelation maintaining integrity for at least 12 h. The study demonstrated that a stomach specific in-situ gel of Meloxicam could be prepared using the floating mechanism to increase the residence time of the drug in the stomach and improve bioavailability and thus improve patient compliance.


Google Scholar

Keywords: Meloxicam, novel gastro retentive, floating in situ gelling system
Statistics
73 Views | 71 Downloads
How to Cite
J, A., A. Y, and A. B. “DEVELOPMENT AND EVALUATION OF IN SITU GELLING GASTRORETENTIVE FORMULATIONS OF MELOXICAM”. Universal Journal of Pharmaceutical Research, Vol. 2, no. 3, May 2017, doi:https://doi.org/10.22270/ujpr.v2i3.R3.
Section
Research Articles